RhumbLine Advisers’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.48M Sell
34,311
-4,765
-12% -$731K ﹤0.01% 1360
2025
Q4
$5.36M Sell
39,076
-3,171
-8% -$410K ﹤0.01% 1365
2025
Q3
$5.13M Sell
42,247
-4,031
-9% -$435K ﹤0.01% 1430
2025
Q2
$4.95M Buy
46,278
+1,232
+3% +$123K ﹤0.01% 1420
2025
Q1
$4.18M Buy
45,046
+1,377
+3% +$133K ﹤0.01% 1450
2024
Q4
$4.7M Sell
43,669
-1,022
-2% -$124K ﹤0.01% 1448
2024
Q3
$5.62M Sell
44,691
-4,930
-10% -$620K 0.01% 1364
2024
Q2
$5.38M Sell
49,621
-750
-1% -$73.1K 0.01% 1358
2024
Q1
$4.76M Sell
50,371
-9,559
-16% -$905K ﹤0.01% 1443
2023
Q4
$5.54M Buy
59,930
+20,375
+52% +$1.56M 0.01% 1353
2023
Q3
$2.53M Sell
39,555
-306
-0.8% -$19.6K ﹤0.01% 1747
2023
Q2
$2.46M Buy
39,861
+751
+2% +$44.5K ﹤0.01% 1792
2023
Q1
$2.27M Buy
39,110
+322
+0.8% +$18.5K ﹤0.01% 1734
2022
Q4
$2.31M Buy
38,788
+268
+0.7% +$16.2K ﹤0.01% 1707
2022
Q3
$2.44M Buy
38,520
+1,443
+4% +$100K ﹤0.01% 1646
2022
Q2
$2.59M Buy
37,077
+841
+2% +$58.9K ﹤0.01% 1632
2022
Q1
$2.54M Sell
36,236
-1,096
-3% -$73.7K ﹤0.01% 1691
2021
Q4
$2.54M Sell
37,332
-218
-0.6% -$15.1K ﹤0.01% 1746
2021
Q3
$2.63M Buy
37,550
+19,150
+104% +$1.39M ﹤0.01% 1741
2021
Q2
$1.29M Sell
18,400
-2,400
-12% -$174K ﹤0.01% 2138
2021
Q1
$1.62M Sell
20,800
-1,231
-6% -$87.1K ﹤0.01% 1996
2020
Q4
$1.46M Buy
22,031
+2,676
+14% +$176K ﹤0.01% 1989
2020
Q3
$1.21M Sell
19,355
-33,615
-63% -$2.1M ﹤0.01% 1916
2020
Q2
$3.36M Buy
52,970
+1,749
+3% +$117K 0.01% 1435
2020
Q1
$3.67M Buy
51,221
+10,148
+25% +$803K 0.01% 1219
2019
Q4
$3.55M Buy
41,073
+335
+0.8% +$28K 0.01% 1468
2019
Q3
$3.33M Buy
40,738
+10,684
+36% +$885K 0.01% 1415
2019
Q2
$2.44M Buy
30,054
+3,002
+11% +$232K ﹤0.01% 1612
2019
Q1
$2.05M Sell
27,052
-6,333
-19% -$502K ﹤0.01% 1693
2018
Q4
$2.62M Buy
33,385
+5,148
+18% +$403K 0.01% 1485
2018
Q3
$2.13M Buy
28,237
+15,834
+128% +$1.17M ﹤0.01% 1621
2018
Q2
$873K Buy
12,403
+775
+7% +$50.7K ﹤0.01% 2066
2018
Q1
$693K Sell
11,628
-675
-5% -$41.4K ﹤0.01% 2092
2017
Q4
$750K Sell
12,303
-3,026
-20% -$193K ﹤0.01% 2075
2017
Q3
$959K Sell
15,329
-10,287
-40% -$663K ﹤0.01% 2001
2017
Q2
$1.8M Sell
25,616
-310
-1% -$22.1K ﹤0.01% 1651
2017
Q1
$1.85M Buy
25,926
+11,680
+82% +$864K ﹤0.01% 1596
2016
Q4
$1.08M Sell
14,246
-1,329
-9% -$92.1K ﹤0.01% 1811
2016
Q3
$1.03M Buy
15,575
+1,634
+12% +$106K ﹤0.01% 1785
2016
Q2
$903K Sell
13,941
-3,159
-18% -$201K ﹤0.01% 1847
2016
Q1
$1.06M Buy
17,100
+1,870
+12% +$116K ﹤0.01% 1747
2015
Q4
$940K Sell
15,230
-220
-1% -$14.3K ﹤0.01% 1843
2015
Q3
$941K Buy
15,450
+841
+6% +$52.6K ﹤0.01% 1800
2015
Q2
$949K Sell
14,609
-980
-6% -$62.2K ﹤0.01% 1897
2015
Q1
$993K Buy
15,589
+800
+5% +$50.8K ﹤0.01% 1861
2014
Q4
$929K Buy
14,789
+1,025
+7% +$61.6K ﹤0.01% 1866
2014
Q3
$764K Buy
13,764
+400
+3% +$22.6K ﹤0.01% 1932
2014
Q2
$752K Sell
13,364
-1,070
-7% -$58.3K ﹤0.01% 2014
2014
Q1
$805K Sell
14,434
-520
-3% -$27.3K ﹤0.01% 1931
2013
Q4
$806K Sell
14,954
-900
-6% -$46K ﹤0.01% 1960
2013
Q3
$749K Sell
15,854
-12,951
-45% -$619K ﹤0.01% 1958
2013
Q2
$1.38M Buy
+28,805
New +$1.34M ﹤0.01% 1554

Other funds holding NHC

RhumbLine Advisers's NHC Position: Q1 2026 in Review

RhumbLine Advisers reduced its National Healthcare (NHC) stake by 12% in Q1 2026, selling an estimated $731K and leaving 34,311 shares worth $5.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

RhumbLine Advisers first reported a position in NHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.62M in Q3 2024. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • RhumbLine Advisers held 34,311 shares of National Healthcare worth $5.48M as of Q1 2026.
  • RhumbLine Advisers sold 4,765 National Healthcare shares in Q1 2026, an estimated $731K.
  • National Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1360 holding.
  • RhumbLine Advisers first reported a position in National Healthcare in Q2 2013 and has held it in 52 quarters since.
  • RhumbLine Advisers's National Healthcare position peaked at $5.62M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.